Related Experiment Videos
Folding intermediates are involved in genetic diseases?
1Institute of Protein Research, Russian Academy of Sciences, Moscow Region.
Abstract:
Recent experimental data show that some human genetic diseases are due to mutations in proteins which influence their trafficking and lead to retaining of proteins in the endoplasmic reticulum or their unproper processing. In this paper a hypothesis is proposed that these mutations are connected with an incomplete protein folding, blocking it at the stage of the kinetic molten globule or even earlier. If so, the specific drugs against these diseases may be ligands and other factors which facilitate the correct protein folding.
Insights
Genetic diseases linked to protein misfolding may be treated by drugs that help proteins fold correctly. This approach targets incomplete protein folding, a potential cause of endoplasmic reticulum retention and improper processing.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Human genetic diseases can arise from mutations affecting protein trafficking.
- Protein mislocalization, such as endoplasmic reticulum retention, is a hallmark of these diseases.
- Improper protein processing contributes to disease pathology.
Purpose of the Study:
- To propose a hypothesis linking genetic diseases to incomplete protein folding.
- To suggest therapeutic strategies targeting protein folding mechanisms.
- To explore the role of the kinetic molten globule state in disease.
Main Methods:
- Review of recent experimental data on protein trafficking and genetic diseases.
- Formulation of a hypothesis based on protein folding kinetics.
- Identification of potential therapeutic targets.
Main Results:
- Experimental data suggest a connection between protein trafficking defects and mutations.
- A hypothesis is proposed that incomplete protein folding underlies these defects.
- The kinetic molten globule stage is identified as a critical point.
Conclusions:
- Mutations causing protein misfolding and endoplasmic reticulum retention may be treatable.
- Ligands and factors facilitating correct protein folding are potential therapeutic agents.
- Targeting protein folding offers a novel strategy for genetic disease treatment.